TUMOR NECROSIS AS A RESULT TO PRE-TRANSPLANT BRIDGING TREATMENT FOR HEPATOCELLULAR CARCINOMA AND ITS EFFECT ON POST-TRANSPLANT OUTCOME

Radunz Sonia; Kirschner Ann-Kathrin; Theysohn Jens M.; Benkoe Tamas

首页> 外文期刊>Transplant international : >TUMOR NECROSIS AS A RESULT TO PRE-TRANSPLANT BRIDGING TREATMENT FOR HEPATOCELLULAR CARCINOMA AND ITS EFFECT ON POST-TRANSPLANT OUTCOME

【24h】

TUMOR NECROSIS AS A RESULT TO PRE-TRANSPLANT BRIDGING TREATMENT FOR HEPATOCELLULAR CARCINOMA AND ITS EFFECT ON POST-TRANSPLANT OUTCOME

机译：肿瘤坏死导致肝细胞癌预移植桥接治疗及其对移植后果的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplant international :》 |2019年第s2期|共1页
作者
Radunz Sonia; Kirschner Ann-Kathrin; Theysohn Jens M.; Benkoe Tamas;
展开▼
作者单位

Univ Hosp Essen Essen Germany;

Univ Hosp Essen Essen Germany;

Univ Hosp Essen Essen Germany;

Univ Hosp Essen Essen Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词
入库时间 2022-08-20 07:41:36

相似文献

外文文献
中文文献
专利

1. TUMOR NECROSIS AS A RESULT TO PRE-TRANSPLANT BRIDGING TREATMENT FOR HEPATOCELLULAR CARCINOMA AND ITS EFFECT ON POST-TRANSPLANT OUTCOME [J] . Radunz Sonia, Kirschner Ann-Kathrin, Theysohn Jens M., Transplant international : . 2019,第S2期

机译：肿瘤坏死导致肝细胞癌预移植桥接治疗及其对移植后果的影响
2. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation [J] . KimP.T.W., OnacaN., ChinnakotlaS., Clinical transplantation. . 2013,第2期

机译：肿瘤生物学和移植前局部治疗确定了接受肝移植的T3肝细胞癌患者的预后
3. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. [J] . Sotiropoulos GC, Malago M, Molmenti EP, European journal of medical research. . 2005,第12期

机译：肝移植术后肝癌完全移植后肿瘤坏死的肝移植患者的病程进行桥接治疗。
4. IL-12 is a Useful Marker to Predict Clinical Outcome in Radiotherapy: Down-Regulation of IL-12 Increases Treatment Failure in Locally Advanced Hepatocellular Carcinoma [C] . En-Jung Lee, Yan-Gun Suh, Seojin Lee, International Molecular Medicine Tri-Conference. . 2015

机译：IL-12是一种有用的标记，可预测放疗中的临床结果：IL-12的下调增加了局部晚期肝细胞癌的治疗失败
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Clinical Outcomes of Ablation Compared with Resection for Single Hepatocellular Carcinoma Lesions as a Primary Treatment or Bridging to Liver Transplantation: A Retrospective Comparative Study [O] . Elizabeth M. Ward, Ahmed Elshawadfy Sherif, Stephen O’Neill, 2021

机译：与单次肝细胞癌病变的切除相比消融的临床结果作为肝移植的主要治疗或桥接：回顾性比较研究
7. Clinical Outcomes of Ablation Compared with Resection for Single Hepatocellular Carcinoma Lesions, as a Primary Treatment or Bridging to Liver Transplantation: A Retrospective Comparative Study [O] . Elizabeth M. Ward, Ahmed Elshawadfy Sherif, Stephen ONeill, 2021

机译：与单次肝细胞癌病变的切除相比消融的临床结果，作为肝移植的主要治疗或桥接：回顾性比较研究

TUMOR NECROSIS AS A RESULT TO PRE-TRANSPLANT BRIDGING TREATMENT FOR HEPATOCELLULAR CARCINOMA AND ITS EFFECT ON POST-TRANSPLANT OUTCOME

著录项

相似文献

相关主题

期刊订阅